CDKN2B-AS1 and hepatocellular carcinoma: Furthermore, the lncRNA CDKN2BAS/miR-153–5p/ARHGAP18 and RP11-386G11.10/miR-345–3p/HNRNPU networks, upregulated in HCC tissues, correlated with larger tumor size, advanced TNM stage, and poorer prognosis in patients (Chen et al., 2018; Xu et al., 2022).